$14.88
-0.28-1.85%
Last update: Oct 29, 4:03 AM
Ascentage Pharma Group International
AAPGNASDAQ
Ascentage Pharma Group (AAPG) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | H1 '26 | H1 '25 | FY '25 |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Estimate | $-0.44 | — | — |
| Actual | $-0.32 | $-0.24 | $-0.50 |
| Surprise | +27.3% | — | — |
| Revenue | |||
| Estimate | $24.1M | — | $83.0M |
| Actual | $44.5M | $32.6M | $82.1M |
| Surprise | +85.0% | — | -1.09% |
| Metric | FY '26E |
|---|---|
| Earnings Per Share (Non-GAAP) | |
| Consensus | $-2.10 |
| Revenue | |
| Consensus | $101.5M |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| H1 | Aug 19, 2026 | $-0.32 | $-0.44 | 27.3 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| H1 | Aug 19, 2026 | $44.54M | $24.07M | 85.0 % |
| FY | Mar 25, 2026 | $82.10M | $83.00M | -1.09 % |
